Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
ViiV Healthcare, majority-owned by GSK, has commenced patent infringement proceedings against Gilead Sciences Inc. in both the United States and Canada. The litigation concerns Gilead’s triple combination HIV drug containing bictegravir, which ViiV alleges infringes its patents covering dolutegravir and related chemic…
Share This Article
Ready-to-post copy includes the article link.
ViiV Healthcare Initiates Patent Infringement Lawsuits Against Gilead Sciences Over Bictegravir in US and Canada ViiV Healthcare, majority-owned by GSK, has commenced patent infringement proceedings against Gilead Sciences Inc. in both the United States and Canada. The litigation concerns Gilead’s triple combination HIV drug conta... Read the full IIPLA article: https://iipla.org/news/viiv-healthcare-initiates-patent-infringement-lawsuits-against-gilead-sciences-over-bictegravir-in-us-and-canada